tru Independence’s Exelixis EXEL Stock Holding History

tru Independence’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-800	Closed	-$19	–	505
2020 Q2	$19	Buy	+800	New	+$18.5K	﹤0.01%	508

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

tru Independence's EXEL Position: Q3 2020 in Review

tru Independence sold out of Exelixis (EXEL) in Q3 2020, closing a stake of 800 shares — an estimated $19 sold.

tru Independence first reported a position in EXEL in Q2 2020 and held it in 1 quarter. The position peaked at $19 in Q2 2020. 367 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

tru Independence reported no remaining Exelixis position as of Q3 2020 after selling out during the quarter.
tru Independence sold 800 Exelixis shares in Q3 2020, an estimated $19.
tru Independence first reported a position in Exelixis in Q2 2020 and held it in 1 quarter.
tru Independence's Exelixis position peaked at $19 in Q2 2020.
367 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.